| Place of Origin: | CHINA |
|---|---|
| Brand Name: | TINGYI |
| Certification: | GMP , ISO 9001:2008 |
| Model Number: | 58186-27-9 |
| Minimum Order Quantity: | 10g |
| Price: | Contact Me |
| Packaging Details: | Disguised Package |
| Delivery Time: | 2 Working Days |
| Payment Terms: | Bank Transfer - Bitcoin - Western Union - MoneyGram |
| Supply Ability: | 100 KG/Month |
| Product Name: | Idebenone | CAS: | 58186-27-9 |
|---|---|---|---|
| Appearance: | Yellow-orange Crystalline Powder | Usage: | Nootropics Drug |
| Shipping Method: | EMS, HKEMS, FEDEX, DHL, UPS, Aramex, ETC | Synonym: | Avan |
| High Light: | pharmaceutical anabolic steroids,pharmaceutical fine chemicals |
||
| Product name | Idebenone |
| Assay | 99% |
| CAS No | 58186-27-9 |
| M.F. | C19H30O5 |
| M.W. | 338.44 |
| Purity | 99.5% |
| Melting Point | 52-55º C |
| Boiling Point | 497.3º C at 760 mmHg |
| Flash Point | 170.1º C |
| Density | 1.08 g/cm3 |
| Storage | Store in room temp |
| Appearance | Yellow-orange crystalline powder |
| Quality Standard | Enterprise Standard |
| Usage | Treatment of depression. |
| Standard | USP/BP |
| Price | Negotiated |
| Minimum order quantity | Negotiated |
| Package | Exquisite and can according to customers' requirement |
| Shipping leading time | Within 8 hours after receiving the payment |
| Payment options | Western Union, MoneyGram, bank transfer , Bitcoin, Litecoin |
| Shipping | Express delivery with DHL, EMS, Fedex, HKEMS, TNT, UPS (within 5-7days after payment) |
COA
| Items of analysis | Specification | Results | ||
| Appearance | yellow or orange yellow crystalline powder | yellow or orange yellow crystalline powder | ||
| Identification | Chemical or IR Method | Positive | ||
| Loss on Drying | ≤0.5% | 0.19% | ||
| Assay (HPLC) | ≥99.0% | 99.34% | ||
| Melting Point | 52~53ºC | 52~53ºC | ||
| Residue on Ignition | ≤0.1% | 0.04% | ||
| Related substance | ≤0.5% | 0.01% | ||
| Heavy Metals | ≤10ppm | <10ppm | ||
| Iron | ≤50ppm | <50ppm | ||
| Sulfate | ≤500ppm | <500ppm | ||
| Arsenic | ≤2ppm | <2ppm | ||
| Lead | ≤3ppm | <3ppm | ||
| Mercury | ≤0.1ppm | <0.1ppm | ||
| Cadmium | ≤1ppm | <1ppm | ||
| Conclusion | Qualified | |||
What are nootropics?
Nootropics also referred to as smart drugs, memory enhancers, neuro enhancers, cognitive enhancers, and intelligence enhancers, aredrugs, supplements, nutraceuticals, and functional foods that purportedly improve mental functions such as cognition, memory, intelligence,motivation, attention, and concentration. Nootropics are thought to work by altering the availability of the brain's supply of neurochemicals (neurotransmitters, enzymes, andhormones), by improving the brain's oxygen supply, or by stimulating nerve growth.
Description
Chemically, idebenone is an organic compound of the quinone family. It is also promoted commercially as a synthetic analog of coenzyme Q10 (CoQ10).
Idebenone (pronounced eye-deb-eh-known, trade names Catena, Raxone, Sovrima, among others) is a drug that was initially developed by Takeda Pharmaceutical Company for the treatment of Alzheimer's disease and other cognitive defects. This has been met with limited success. The Swiss company Santhera Pharmaceuticals has started to investigate it for the treatment of neuromuscular diseases. In 2010, early clinical trials for the treatment of Friedreich's ataxia and Duchenne muscular dystrophy have been completed. As of December 2013 the drug is not approved for these indications in North America or Europe, but it is approved for the treatment of Leber's hereditary optic neuropathy (LHON) in Europe.
Application
Idebenone is used for Alzheimer's disease, liver disease, and heart disease; as well as a number of inherited disorders including Leber's disease (an eye condition), mitochondrial encephalomyopathies (nerve and muscle disorders), and Friedreich's ataxia (a nervous system disorder that worsens over time, producing gait and speech problems, and eventually leading toward heart disease and diabetes).
Idebenone is an organic compound belonging to the quinone family, being similar to coenzyme Q-10. It is a kind of drug developed by Takeda Pharmaceutical Company for the treatment of Alzheimer’s disease and some other cognitive defects. However, these have been not very much progress associated with this indication. It is now also used for the treatment of Friedreich’s ataxia with a positive effect on cardiac hypertrophy and neurological function.
However, this indication is only approved in Canada, not in Europe and US. It is now under investigation on its efficacy for the treatment of Duchenne muscular dystrophy, Leber’s hereditary optic neuropathy, mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes) as well as primary progressive multiple sclerosis. The efficacy of this drug still demands more evidences.
Function
1.Idebenone increases nerve growth factor (NGF) in the brain.
2.Idebenone is a powerful antioxidant and positively affects brain chemistry.
3.Idebenone has been shown to promote information transfer across the corpus callosum, the membrane separating the right and left brain hemispheres.
4. Idebenone has been used to treat Alzheimer's and to lessen damage from strokes.
5. Idebenone can increase production of the brain neurotransmitters serotonin, dopamine, adrenalin, and noradrenanlin.
